Lea Botermann
Impact in
- Family Practice top 2%
- Medication Adherence and Compliance
- Geriatrics and Gerontology top 2%
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Medication Adherence and Compliance 8
-
- Pharmaceutical Practices and Patient Outcomes 5
- Co-authors
- Samuel Allemann (1 shared paper)Nina Griese (1 shared paper)J. W. Foppe van Mil (1 shared paper)Karin Berger (1 shared paper)Kurt E. Hersberger (1 shared paper)Martin Schulz (7 shared papers)Ulrich Laufs (5 shared papers)Nina Griese‐Mammen (4 shared papers)
- Journals
- Patient Preference and Adherence (1 paper)International Journal of Cardiology (1 paper)Heart Failure Reviews (1 paper)Canadian Pharmacists Journal / Revue des Pharmaciens du Canada (1 paper)European Journal of Clinical Pharmacology (1 paper)
- Partner nations
- GermanySwitzerland
In The Last Decade
Lea Botermann
9 papers receiving 283 citations
Peers
Comparison fields: 5 of 53
- Family Practice 148
- Geriatrics and Gerontology 175
- Applied Microbiology and Biotechnology 20
- Toxicology 15
- Medical Terminology 1
Countries citing papers authored by Lea Botermann
This map shows the geographic impact of Lea Botermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lea Botermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lea Botermann more than expected).
Fields of papers citing papers by Lea Botermann
This network shows the impact of papers produced by Lea Botermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lea Botermann. The network helps show where Lea Botermann may publish in the future.
Co-authors
The 23 scholars most cited alongside Lea Botermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 148 | |
| 2 | 2015 | 65 | |
| 3 | 2017 | 27 | |
| 4 | 2016 | 15 | |
| 5 | 2016 | 15 | |
| 6 | 2018 | 14 | |
| 7 | 2018 | 4 | |
| 8 | 2017 | 3 | |
| 9 | 2022 | 3 |
About Lea Botermann
Lea Botermann is a scholar working on Family Practice, Geriatrics and Gerontology, Cardiology and Cardiovascular Medicine, Pediatrics, Perinatology and Child Health and Psychiatry and Mental health, having authored 9 papers that have together received 294 indexed citations. Recurring topics across this work include Medication Adherence and Compliance (8 papers), Pharmaceutical Practices and Patient Outcomes (5 papers), Pharmaceutical studies and practices (4 papers), Heart Failure Treatment and Management (4 papers), Bipolar Disorder and Treatment (3 papers), Health Systems, Economic Evaluations, Quality of Life (1 paper), Diabetes Treatment and Management (1 paper) and Patient Safety and Medication Errors (1 paper). The work is most often cited by research in Family Practice (148 citations), Geriatrics and Gerontology (175 citations), Applied Microbiology and Biotechnology (20 citations), Toxicology (15 citations) and Medical Terminology (1 citation). Lea Botermann has collaborated with scholars based in Germany and Switzerland. Frequent co-authors include Samuel Allemann, Nina Griese, J. W. Foppe van Mil, Karin Berger, Kurt E. Hersberger, Martin Schulz, Ulrich Laufs, Nina Griese‐Mammen, Susanne Gabriele Schorr and Charlotte Kloft. Their work appears in journals such as Patient Preference and Adherence, International Journal of Cardiology, Heart Failure Reviews, Canadian Pharmacists Journal / Revue des Pharmaciens du Canada and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.